SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-20-130095
Filing Date
2020-11-27
Accepted
2020-11-27 17:24:12
Documents
5
Period of Report
2020-11-27

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2036029d5_6k.htm 6-K 10341
2 EXHIBIT 99.1 tm2036029d5_ex99-1.htm EX-99.1 3977
3 EXHIBIT 99.2 tm2036029d5_ex99-2.htm EX-99.2 4243
4 GRAPHIC tm2036029d5_ex99-1img01.jpg GRAPHIC 19548
5 GRAPHIC tm2036029d5_ex99-2img01.jpg GRAPHIC 4399
  Complete submission text file 0001104659-20-130095.txt   52875
Mailing Address 245 TALBOT STREET W., SUITE 103 LEAMINGTON A6 N8H 1N8
Business Address 245 TALBOT STREET W., SUITE 103 LEAMINGTON A6 N8H 1N8 (844) 427-4742
Aphria Inc. (Filer) CIK: 0001733418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-38708 | Film No.: 201355929
SIC: 2833 Medicinal Chemicals & Botanical Products